Categories: News

Completion of Name Change and Consolidation

VANCOUVER, BC / ACCESSWIRE / March 28, 2019 / Canland Health Corp. (formerly, 1155176 B.C. LTD.) (the “Company“) is pleased to announce that effective March 27, 2019 it has completed its name change from “1155176 B.C. LTD.” to “Canland Health Corp.” and the consolidation of its issued and outstanding class A common shares on the basis of 50 pre-consolidation shares for each 1 post-consolidation share for shareholders of record as of the end of business day on March 27, 2019. No fractional shares have been issued as a result of the consolidation and fractional shares have been rounded down to the nearest whole number of shares. The Company’s new CUSIP number is “137640108”.

For further information please contact:

Ron Miles, CEO & Director
E-mail: rmiles1@telus.net

Statements contained in this press release are made as of the date of this press release. The Company disclaims any intent or obligation to update publicly any forward-looking information or other information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

SOURCE: Canland Health Corp.

View source version on accesswire.com:
https://www.accesswire.com/540591/Completion-of-Name-Change-and-Consolidation

user

Recent Posts

NervGen Pharma Announces Proposed Amendment to Warrants

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…

6 hours ago

MyndTec Inc. Completes Ninth Tranche of Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - December 12, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"),…

8 hours ago

Dominari Holdings Announces Change of Record Date and Payment Date for $10 Million Cash Dividend

NEW YORK, Dec. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce…

8 hours ago

ISHI Health Launches Virtual Heart Failure Clinics in California and Arizona

SAN DIEGO, Dec. 12, 2025 /PRNewswire/ -- ISHI Health, an innovator in AI-enabled virtual cardiac…

8 hours ago

Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care

LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight…

8 hours ago

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP)…

8 hours ago